Underrepresentation of women as participants and researchers in CV clinical trials remains a problem, asserts a review ...
After guideline changes, aspirin use dropped off overall, even for higher-risk patients in whom it might still be considered.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback